Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talia Flanagan

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology in Drug Development|February 13, 2019
Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption InhibitorZancong Shen, Caroline A Lee, Shakti Valdez, et al.
Pharmaceutics|April 28, 2023
Characterization of Aspirated Duodenal Fluids from Parkinson's Disease PatientsTom de Waal, Joachim Brouwers, Philippe Berben, et al.
Pharmaceutics|December 28, 2019
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory PerspectivesMark McAllister, Talia Flanagan, Karin Boon, et al.
The AAPS Journal|July 29, 2020
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug ProductsArzu Selen, Anette Müllertz, Filippos Kesisoglou, et al.
The AAPS Journal|December 3, 2020
Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug ProductsArzu Selen, Anette Müllertz, Filippos Kesisoglou, et al.
Drugs|October 3, 2014
Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populationsFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
Journal of Pharmaceutical Sciences|July 3, 2019
Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These ChangesDomagoj Segregur, Talia Flanagan, James Mann, et al.
International Journal of Pharmaceutics|May 12, 2015
Formulation factors affecting acceptability of oral medicines in childrenFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
Molecular Pharmaceutics|November 13, 2023
Contribution of the Dynamic Intestinal Absorption Model (Diamod) to the Development of a Patient-Centric Drug FormulationFrédéric Moens, Adam Larsson, Anke De Blaiser, et al.
The AAPS Journal|September 28, 2022
Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and VaccinesMatthew E Popkin, Markus Goese, Diane Wilkinson, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology in Drug Development|February 13, 2019
Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption InhibitorZancong Shen, Caroline A Lee, Shakti Valdez, et al.
Pharmaceutics|April 28, 2023
Characterization of Aspirated Duodenal Fluids from Parkinson's Disease PatientsTom de Waal, Joachim Brouwers, Philippe Berben, et al.
Pharmaceutics|December 28, 2019
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory PerspectivesMark McAllister, Talia Flanagan, Karin Boon, et al.
The AAPS Journal|July 29, 2020
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug ProductsArzu Selen, Anette Müllertz, Filippos Kesisoglou, et al.
The AAPS Journal|December 3, 2020
Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug ProductsArzu Selen, Anette Müllertz, Filippos Kesisoglou, et al.
Drugs|October 3, 2014
Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populationsFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
Journal of Pharmaceutical Sciences|July 3, 2019
Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These ChangesDomagoj Segregur, Talia Flanagan, James Mann, et al.
International Journal of Pharmaceutics|May 12, 2015
Formulation factors affecting acceptability of oral medicines in childrenFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
Molecular Pharmaceutics|November 13, 2023
Contribution of the Dynamic Intestinal Absorption Model (Diamod) to the Development of a Patient-Centric Drug FormulationFrédéric Moens, Adam Larsson, Anke De Blaiser, et al.
The AAPS Journal|September 28, 2022
Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and VaccinesMatthew E Popkin, Markus Goese, Diane Wilkinson, et al.
Pageof 3